Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
F-Prime Capital Partners Life Sciences Fund Vii Lp investment portfolio
F-Prime Capital Partners Life Sciences Fund Vii Lp has made numerous investments in companies such as Tenpoint Therapeutics Holding, T-Therapeutics, and Proximie within the Healthcare & Life Sciences sector.
vc
Portfolio
7
Team
0
Portfolio (7)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Aviadobio Ltd AviadoBio creates gene‑therapy medicines and delivery technologies that target neurodegenerative disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, Alzheimer’s disease, tauopathies and retinal conditions. Its platform combines next‑generation gene‑therapy design with neuroscience expertise and a neuroanatomy‑led approach to deliver treatments to the brain and eye. | Healthcare & Life Sciences | London | Confirmed | 2025-12-19 |
| Proximie Limited | — | Altrincham | Confirmed | 2025-12-04 |
Shareholding changes (6)
F-Prime Capital Partners Life Sciences Fund Vii Lp's positions across portfolio companies2026
- SERIES A 9,959,999 → 0
- SERIES SEED 1,617,920 → 0
- SERIES A1 0 → 9,959,999
- SERIES A2 0 → 1,492,189
- SERIES B1 0 → 806,011
- SERIES B2 0 → 4,573,641
- SERIES B3 0 → 1,392,976
- SERIES SEED 1 0 → 1,617,920
- SERIES SEED 2 0 → 242,392
- SERIES A 70,539,424 → 0
- SERIES A-2 0 → 48,397,635
- SERIES A-1 0 → 62,240,668